Please try another search
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a class of Tissue-Specific Therapeutics (TSTx) in oncology and inflammation. Its lead asset, IMX-110, is in Phase Ib/IIa clinical trials for solid tumors in the United States and Australia. IMX-110 is a negatively charged TSTx that simultaneously disables resistance pathways with a poly-kinase inhibitor (which inhibits multiple kinases simultaneously) and induces tumor cell death with an apoptosis inducer (which activates apoptosis, a non-inflammatory programmed cell death pathway), leveraging its TME Normalization Technology, delivered deep into the tumor micro-environment (TME). Its TME Normalization Technology allows its drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its other drug candidates include IMX-111 and IMX-120. IMX-111 and IMX-120 are under development for colorectal cancer and inflammatory bowel disease.
Name | Age | Since | Title |
---|---|---|---|
Magda Marquet | 63 | 2021 | Independent Director |
Gabriel Morris | 36 | 2021 | CFO & Director |
Sant Chawla | - | - | Member of Scientific Advisory Board |
Helen C. Adams | 62 | 2021 | Independent Director |
Jane Melissa Buchan | 58 | 2021 | Independent Director |
Ilya Rachman | 50 | 2012 | Co-Founder, CEO & Chairman |
Yekaterina Chudnovsky | 38 | 2023 | Director |
Gary J. Schiller | - | - | Member of Scientific Advisory Board |
Razelle Kurzrock | - | - | Member of Scientific Advisory Board |
Jason Hsu | 48 | 2014 | Director |
Galit Lahav | - | 2021 | Member of Scientific Advisory Board |
Heather Landau | - | 2023 | Member of Scientific Advisory Board |
Michaela Liedtke | - | 2023 | Member of Scientific Advisory Board |
George W. Sledge | 71 | - | Member of Scientific Advisory Board |
Larry Norton | 76 | - | Member of Scientific Advisory Board |
Carey J. Ng | 44 | 2019 | Independent Director |
Suzanne Lentzsch | - | 2023 | Member of Scientific Advisory Board |
Marko Radic | - | 2023 | Member of Scientific Advisory Board |
Vaishali Sanchorawala | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review